KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Basic) (2016 - 2025)

Charles River Laboratories International has reported EPS (Basic) over the past 17 years, most recently at -$5.57 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$5.57 for Q4 2025, down 32.94% from a year ago — trailing twelve months through Dec 2025 was -$2.9 (down 1480.95% YoY), and the annual figure for FY2025 was -$2.91, down 1555.0%.
  • EPS (Basic) for Q4 2025 was -$5.57 at Charles River Laboratories International, down from $1.11 in the prior quarter.
  • Over the last five years, EPS (Basic) for CRL hit a ceiling of $3.69 in Q4 2022 and a floor of -$5.57 in Q4 2025.
  • Median EPS (Basic) over the past 5 years was $1.76 (2024), compared with a mean of $1.2.
  • Biggest five-year swings in EPS (Basic): soared 49.59% in 2022 and later plummeted 214.79% in 2024.
  • Charles River Laboratories International's EPS (Basic) stood at $2.73 in 2021, then skyrocketed by 35.16% to $3.69 in 2022, then decreased by 1.08% to $3.65 in 2023, then plummeted by 214.79% to -$4.19 in 2024, then crashed by 32.94% to -$5.57 in 2025.
  • The last three reported values for EPS (Basic) were -$5.57 (Q4 2025), $1.11 (Q3 2025), and $1.06 (Q2 2025) per Business Quant data.